Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBT (2016 - 2025)

Ocugen (OCGN) has disclosed EBT for 12 consecutive years, with -$16.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 20.67% year-over-year to -$16.9 million, compared with a TTM value of -$63.3 million through Dec 2025, down 17.01%, and an annual FY2025 reading of -$67.2 million, down 23.97% over the prior year.
  • EBT was -$16.9 million for Q4 2025 at Ocugen, down from -$16.2 million in the prior quarter.
  • Across five years, EBT topped out at -$7.1 million in Q1 2021 and bottomed at -$28.4 million in Q4 2022.
  • Average EBT over 5 years is -$16.5 million, with a median of -$15.3 million recorded in 2024.
  • The sharpest move saw EBT tumbled 609.19% in 2021, then skyrocketed 59.35% in 2023.
  • Year by year, EBT stood at -$14.6 million in 2021, then plummeted by 94.45% to -$28.4 million in 2022, then surged by 59.35% to -$11.5 million in 2023, then dropped by 21.17% to -$14.0 million in 2024, then fell by 20.67% to -$16.9 million in 2025.
  • Business Quant data shows EBT for OCGN at -$16.9 million in Q4 2025, -$16.2 million in Q3 2025, and -$14.9 million in Q2 2025.